Mahnaz Taherianfard
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Mahnaz Taherianfard has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
- Soodeh Rowhanirad
Shiraz University, Shiraz, Iran
3 shared publications - Tahoora Shomali
Division of Pharmacology and Toxicology, Department of Basic Sciences, School of Veterinary Medicine, Shiraz University, Shiraz, Iran
3 shared publications Mehdi Fazeli
Department of Pharmacology and Toxicology, Department of Basic Sciences, School of Veterinary Medicine, Shiraz University, Shiraz, Iran
2 shared publicationsMohabbat Ahmadi
Physiology division of Basic Science Department, School of Vet Med; Shiraz University, Shiraz, Iran
2 shared publicationsTahora Shomali
Pharmacology division of Basic Science Department, School of Vet Med; Shiraz University, Shiraz, Iran
2 shared publicationsA Bahaoddini
1 shared publication
Latest Publications
- Open Access
- 30 June 2026
- Published by Brieflands in Journal of Kermanshah University of Medical Sciences
- Vol. 30 (2) , e173063
Brain Serotonin 5-HT2α Receptor Density in Male Rats Can Be Affected by Bisphenol A and Passive Avoidance Learning
Background: Bisphenol A (BPA) may adversely affect the nervous system. Objectives: This study aimed to assess the effects of passive avoidance learning on BPA-induced toxicity, as indicated by serotonin 5-HT2α receptor density in the cerebellum, basolateral amygdala, and hippocampus of male rats. Methods: Thirty male rats (200 - 220 g) were allocated to six experimental groups. BPA was administered orally for 15 consecutive days. Learning and memory performance were assessed using a passive avoidance shuttle-box paradigm. Serotonin 5-HT2α receptor density was evaluated by immunohistochemistry in the selected brain regions. Immunohistochemical labeling was quantified by measuring color parameters using image-analysis software. Results: BPA at both doses reduced 5-HT2α serotonin receptor density in the examined brain structures. Passive avoidance learning mitigated the toxic effects of BPA on 5-HT2α receptor density in these structures. Conclusions: Overall, BPA exposure downregulated 5-HT2α receptors in the hippocampus, amygdala, and cerebellum of male rats, whereas passive avoidance learning and memory were associated with an increased receptor density.
- 30 June 2026
- Published by Brieflands in Journal of Kermanshah University of Medical Sciences
- Vol. 30 (2) , e173063
Open AccessBrain Serotonin 5-HT2α Receptor Density in Male Rats Can Be Affected by Bisphenol A and Passive Avoidance Learning
Background: Bisphenol A (BPA) may adversely affect the nervous system. Objectives: This study aimed to assess the effects of passive avoidance learning on BPA-induced toxicity, as indicated by serotonin 5-HT2α receptor density in the cerebellum, basolateral amygdala, and hippocampus of male rats. Methods: Thirty male rats (200 - 220 g) were allocated to six experimental groups. BPA was administered orally for 15 consecutive days. Learning and memory performance were assessed using a passive avoidance shuttle-box paradigm. Serotonin 5-HT2α receptor density was evaluated by immunohistochemistry in the selected brain regions. Immunohistochemical labeling was quantified by measuring color parameters using image-analysis software. Results: BPA at both doses reduced 5-HT2α serotonin receptor density in the examined brain structures. Passive avoidance learning mitigated the toxic effects of BPA on 5-HT2α receptor density in these structures. Conclusions: Overall, BPA exposure downregulated 5-HT2α receptors in the hippocampus, amygdala, and cerebellum of male rats, whereas passive avoidance learning and memory were associated with an increased receptor density.
- 1 October 2024
- Published by Apex Publishing in Scientific Journal of Kurdistan University of Medical Sciences
- Vol. 29 (4) , 82-94
Hematological Factors and MRI in Covid-19 Infected may Predict the Prevalence of Multiple Sclerosis in the Post-Covid era
- 1 October 2024
- Published by Apex Publishing in Scientific Journal of Kurdistan University of Medical Sciences
- Vol. 29 (4) , 82-94
Hematological Factors and MRI in Covid-19 Infected may Predict the Prevalence of Multiple Sclerosis in the Post-Covid era
- Open Access
- 19 August 2023
- Published by Wiley
Chalcones accelerate the recovery period after cuprizone-induced noxious changes in the C57BL/6 mice model
Multiple sclerosis (MS) is the most common demyelinating disorders of the CNS. Despite advancements in medicine, there remains an absence of an efficient cure without side effects and MS patients suffer from the progressive symptoms. On the other hand, the impact of natural compounds and the mechanisms of their actions in ameliorating neurodegenerative disorders have been poorly known. The current study investigated the effect of Chalcones from Ashitaba (ChA) on accelerating the recovery period in the Cuprizone model. The control group with no Cuprizone or ChA treatment (CNT), Cuprizone-exposed 1 and 2 (CPZ1, CPZ2) groups with 0.2% Cuprizone feeding for five weeks without and with recovery period; respectively. And ChA-treated (Treated1, Treated2) groups received ChA at 300 or 600 mg/kg/day; respectively, for 2 weeks following cuprizone removal. The degree of demyelination in the corpus callosum (CC), impairment of cognitive function, and serum and brain levels of Brain-Derived Neurotrophic Factor (BDNF) and Tumor Necrosis Factor Alpha (TNFα) were evaluated by the histological, Y-maze, and enzyme-linked immunosorbent assay (ELISA) tests, respectively. The results demonstrated that the ChA treatment significantly improved the serum and brain levels of BDNF and the behavioral responses compared to the CPZ-exposed groups. Moreover, the ChA-treated groups had a significant decrease in the serum and brain TNFα levels and the extent of CC demyelination compared to the CPZ-exposed groups. The present study showed that ChA treatment for 2 weeks accelerated remyelination of the CC through suppressing inflammation caused by TNFα and promoting myelination resulted from BDNF.
- 19 August 2023
- Published by Wiley
Open AccessChalcones accelerate the recovery period after cuprizone-induced noxious changes in the C57BL/6 mice model
Multiple sclerosis (MS) is the most common demyelinating disorders of the CNS. Despite advancements in medicine, there remains an absence of an efficient cure without side effects and MS patients suffer from the progressive symptoms. On the other hand, the impact of natural compounds and the mechanisms of their actions in ameliorating neurodegenerative disorders have been poorly known. The current study investigated the effect of Chalcones from Ashitaba (ChA) on accelerating the recovery period in the Cuprizone model. The control group with no Cuprizone or ChA treatment (CNT), Cuprizone-exposed 1 and 2 (CPZ1, CPZ2) groups with 0.2% Cuprizone feeding for five weeks without and with recovery period; respectively. And ChA-treated (Treated1, Treated2) groups received ChA at 300 or 600 mg/kg/day; respectively, for 2 weeks following cuprizone removal. The degree of demyelination in the corpus callosum (CC), impairment of cognitive function, and serum and brain levels of Brain-Derived Neurotrophic Factor (BDNF) and Tumor Necrosis Factor Alpha (TNFα) were evaluated by the histological, Y-maze, and enzyme-linked immunosorbent assay (ELISA) tests, respectively. The results demonstrated that the ChA treatment significantly improved the serum and brain levels of BDNF and the behavioral responses compared to the CPZ-exposed groups. Moreover, the ChA-treated groups had a significant decrease in the serum and brain TNFα levels and the extent of CC demyelination compared to the CPZ-exposed groups. The present study showed that ChA treatment for 2 weeks accelerated remyelination of the CC through suppressing inflammation caused by TNFα and promoting myelination resulted from BDNF.
- Open Access
- 4 July 2023
- Published by Wiley in Brain and Behavior
- Vol. 13 (9) , e3144
The neuroprotective effects of Chalcones from Ashitaba on cuprizone‐induced demyelination via modulation of brain‐derived neurotrophic factor and tumor necrosis factor α
Introduction: Multiple sclerosis (MS) is the most common demyelinating disease of the central nervous system. However, the limitations of available therapeutic strategies are frustrating, both in terms of their low efficacy and multiple side effects. Previous studies showed that natural compounds such as Chalcones possess neuroprotective effects on neurodegenerative disorders. However, few studies have so far been published on the potential effects of Chalcones on treating demyelinating disease. The present study was designed to investigate the effects of Chalcones from Ashitaba (ChA) on cuprizone‐induced noxious changes in the C57BL6 mice model of MS.Methods: The mice received normal diets (Control group: CNT), or Cuprizone‐supplemented diets either without ChA (Cuprizone group: CPZ) or with low or high (300, 600 mg/kg/day) doses of ChA (ChA‐treated groups: CPZ+ChA300/600). Brain‐derived neurotrophic factor (BDNF) and tumor necrosis factor alpha (TNFα) levels, demyelination scores in the corpus callosum (CC), and cognitive impairment were evaluated using the enzyme‐linked immunosorbent assay, histological, and Y‐maze tests, respectively.Results: The findings showed that ChA Co‐treatment significantly reduced the extent of demyelination in the CC and the serum and brain levels of TNFα in the ChA‐treated groups compared to the CPZ group. Besides, treatment with a higher dose of ChA significantly improved the behavioral responses and BDNF levels in the serum and brain of the CPZ+ChA600 group when compared with the CPZ group.Conclusion: The present study provided evidence for the neuroprotective effects of ChA on cuprizone‐induced demyelination and behavioral dysfunction in C57BL/6 mice, possibly by modulating TNFα secretion and BDNF expression.
- 4 July 2023
- Published by Wiley in Brain and Behavior
- Vol. 13 (9) , e3144
Open AccessThe neuroprotective effects of Chalcones from Ashitaba on cuprizone‐induced demyelination via modulation of brain‐derived neurotrophic factor and tumor necrosis factor α
Introduction: Multiple sclerosis (MS) is the most common demyelinating disease of the central nervous system. However, the limitations of available therapeutic strategies are frustrating, both in terms of their low efficacy and multiple side effects. Previous studies showed that natural compounds such as Chalcones possess neuroprotective effects on neurodegenerative disorders. However, few studies have so far been published on the potential effects of Chalcones on treating demyelinating disease. The present study was designed to investigate the effects of Chalcones from Ashitaba (ChA) on cuprizone‐induced noxious changes in the C57BL6 mice model of MS.Methods: The mice received normal diets (Control group: CNT), or Cuprizone‐supplemented diets either without ChA (Cuprizone group: CPZ) or with low or high (300, 600 mg/kg/day) doses of ChA (ChA‐treated groups: CPZ+ChA300/600). Brain‐derived neurotrophic factor (BDNF) and tumor necrosis factor alpha (TNFα) levels, demyelination scores in the corpus callosum (CC), and cognitive impairment were evaluated using the enzyme‐linked immunosorbent assay, histological, and Y‐maze tests, respectively.Results: The findings showed that ChA Co‐treatment significantly reduced the extent of demyelination in the CC and the serum and brain levels of TNFα in the ChA‐treated groups compared to the CPZ group. Besides, treatment with a higher dose of ChA significantly improved the behavioral responses and BDNF levels in the serum and brain of the CPZ+ChA600 group when compared with the CPZ group.Conclusion: The present study provided evidence for the neuroprotective effects of ChA on cuprizone‐induced demyelination and behavioral dysfunction in C57BL/6 mice, possibly by modulating TNFα secretion and BDNF expression.
- Open Access
- 6 March 2023
- Published by Wiley in Brain and Behavior
- Vol. 13 (4)
The passive avoidance task ameliorate the toxic effects of bisphenol A on dopamine D1 receptor density in hippocampus, amygdala, and cerebellum of male rats
Introduction: Dopamine D1 receptor seems to play a role in mediating plasticity. Therefore, the present study aimed to investigate the effects of passive avoidance tasks postexposed to BPA on dopamine D1 receptor density in the hippocampus, amygdala, and cerebellum of male rats.Methods: Thirty‐five male Sprague–Dawley rats weighing 220.300 g, in standard light‐dark 12 h light/12 h dark were used in the present study; water and food were ad libitum. Animals were divided into six groups. Administration of BPA 5 and 50 mg/kg/day were gavaged for 15 days. Learning and memory assessment were done by a shuttle box after 15 days of BPA administration. The density of the dopamine D1 receptor was investigated using an immunohistochemistry (IH) procedure. For determining the color difference in IH sections, Image Analyzer software was used. The data were analyzed by one‐way ANOVA followed by Tukey's as a post hoc test.Results: The data showed that BPA in both doses could significantly increase the density of dopamine D1 receptors in the hippocampus, amygdala, and cerebellum of male rats; learning in rats postexposed to BPA improves dopamine D1 receptor density significantly in three brain structures.Discussion: According to the results, passive avoidance learning and memory can improve the density of dopamine D1 receptors in the hippocampus, amygdala, and cerebellum of male rats.
- 6 March 2023
- Published by Wiley in Brain and Behavior
- Vol. 13 (4)
Open AccessThe passive avoidance task ameliorate the toxic effects of bisphenol A on dopamine D1 receptor density in hippocampus, amygdala, and cerebellum of male rats
Introduction: Dopamine D1 receptor seems to play a role in mediating plasticity. Therefore, the present study aimed to investigate the effects of passive avoidance tasks postexposed to BPA on dopamine D1 receptor density in the hippocampus, amygdala, and cerebellum of male rats.Methods: Thirty‐five male Sprague–Dawley rats weighing 220.300 g, in standard light‐dark 12 h light/12 h dark were used in the present study; water and food were ad libitum. Animals were divided into six groups. Administration of BPA 5 and 50 mg/kg/day were gavaged for 15 days. Learning and memory assessment were done by a shuttle box after 15 days of BPA administration. The density of the dopamine D1 receptor was investigated using an immunohistochemistry (IH) procedure. For determining the color difference in IH sections, Image Analyzer software was used. The data were analyzed by one‐way ANOVA followed by Tukey's as a post hoc test.Results: The data showed that BPA in both doses could significantly increase the density of dopamine D1 receptors in the hippocampus, amygdala, and cerebellum of male rats; learning in rats postexposed to BPA improves dopamine D1 receptor density significantly in three brain structures.Discussion: According to the results, passive avoidance learning and memory can improve the density of dopamine D1 receptors in the hippocampus, amygdala, and cerebellum of male rats.
- Open Access
- 1 December 2021
- Published by CMV Verlag in Physiology and Pharmacology
- Vol. 25 (4) , 353-362
Royal jelly attenuated cognitive and non-cognitive deficits and blood-brain barrier disruption inducedby ethidium bromide
Introduction: Multiple sclerosis (MS) is an autoimmune disease. The main aims of the present investigation were to evaluate the effect of royal jelly (RJ) on cognitive and non-cognitive behavior, demyelination and the level of blood-brain barrier (BBB) disruption induced by ethidium bromide (EB). Methods: Twenty-five adult male Sprague Dawley in ...
- 1 December 2021
- Published by CMV Verlag in Physiology and Pharmacology
- Vol. 25 (4) , 353-362
Open AccessRoyal jelly attenuated cognitive and non-cognitive deficits and blood-brain barrier disruption inducedby ethidium bromide
Introduction: Multiple sclerosis (MS) is an autoimmune disease. The main aims of the present investigation were to evaluate the effect of royal jelly (RJ) on cognitive and non-cognitive behavior, demyelination and the level of blood-brain barrier (BBB) disruption induced by ethidium bromide (EB). Methods: Twenty-five adult male Sprague Dawley in ...
- Open Access
- 19 January 2021
- Published by Knowledge E DMCC in Journal of Family & Reproductive Health
- Vol. 14 (4) , 259-268
Assessing Pain Behavioral Responses and Neurotrophic Factors in the Dorsal Root Ganglion, Serum and Peritoneal Fluid in Rat Models of Endometriosis
Objective: Pain is the most frequently reported symptom involving in endometriosis. The alterations of neurotrophic factors and certain neuropeptides in the dorsal root ganglion (DRG), as well as serum and peritoneal fluid (PF), were evaluated in rat models of endometriosis. Materials and methods: Twenty-four Sprague Dawley female rats were selected and maintained in a standard condition with 12 hours’ dark-light cycles. All the rats were randomly assigned to 3 groups: Control (intact rats); Sham (the operation was conducted without endometriosis induction); and Endometriosis (endometriosis induction was performed). The formalin test was performed for all groups on the first and the 21st day of the study. The assessments of Brain-Derived Neurotrophic Factor (BDNF), Nerve Growth Factor (NGF), Calcitonin Gene-Related Peptide (CGRP), and Substance P levels were carried out by enzyme-linked immunosorbent assay (Elisa). The data were analyzed by One-Way ANOVA. The Tukey’s test was used as post-hoc. Results: Endometriosis induction significantly increased the mean pain scores in the endometriosis group in all three phases of the formalin test. The concentrations of DRG-CGRP (p=0.035), BDNF (p<0.001), and NGF (p=0.006) in the endometriosis group were significantly higher than that of the other groups while serum-BDNF (p<0.001), Substance P (p=0.009), and NGF (p=0.015) were significantly lower in endometriosis group compared to other groups. The concentrations of PF-BDNF (p=0.025) and Substance P (p=0.009) were significantly lower than those of other groups. Conclusion: The present results delineate that endometriosis induction could lead to hyperalgesia. This may be related to the significant increases in the BDNF, NGF, and CGRP in DRG.
- 19 January 2021
- Published by Knowledge E DMCC in Journal of Family & Reproductive Health
- Vol. 14 (4) , 259-268
Open AccessAssessing Pain Behavioral Responses and Neurotrophic Factors in the Dorsal Root Ganglion, Serum and Peritoneal Fluid in Rat Models of Endometriosis
Objective: Pain is the most frequently reported symptom involving in endometriosis. The alterations of neurotrophic factors and certain neuropeptides in the dorsal root ganglion (DRG), as well as serum and peritoneal fluid (PF), were evaluated in rat models of endometriosis. Materials and methods: Twenty-four Sprague Dawley female rats were selected and maintained in a standard condition with 12 hours’ dark-light cycles. All the rats were randomly assigned to 3 groups: Control (intact rats); Sham (the operation was conducted without endometriosis induction); and Endometriosis (endometriosis induction was performed). The formalin test was performed for all groups on the first and the 21st day of the study. The assessments of Brain-Derived Neurotrophic Factor (BDNF), Nerve Growth Factor (NGF), Calcitonin Gene-Related Peptide (CGRP), and Substance P levels were carried out by enzyme-linked immunosorbent assay (Elisa). The data were analyzed by One-Way ANOVA. The Tukey’s test was used as post-hoc. Results: Endometriosis induction significantly increased the mean pain scores in the endometriosis group in all three phases of the formalin test. The concentrations of DRG-CGRP (p=0.035), BDNF (p<0.001), and NGF (p=0.006) in the endometriosis group were significantly higher than that of the other groups while serum-BDNF (p<0.001), Substance P (p=0.009), and NGF (p=0.015) were significantly lower in endometriosis group compared to other groups. The concentrations of PF-BDNF (p=0.025) and Substance P (p=0.009) were significantly lower than those of other groups. Conclusion: The present results delineate that endometriosis induction could lead to hyperalgesia. This may be related to the significant increases in the BDNF, NGF, and CGRP in DRG.
- Open Access
- 1 September 2020
- Published by Negah Scientific Publisher in Basic and Clinical Neuroscience Journal
- Vol. 11 (5) , 587-594
Effects of Pretreatment With Ginseng Extract on Dopamine D2 Receptor Analgesi
Introduction: The ginseng extract is an herb that has been used for many purposes such as analgesic effect. Dopamine D2 receptors are involved in the regulation of pain in humans. Therefore, the present investigation aims to study how pretreatment with aqueous-alcoholic extract of ginseng can affect dopamine D2 receptors’ pain sensitivity. Methods: We used 45 adult male rats weighing 250±20 for this study. Animals were maintained in a standard condition at a temperature of 21°C-24°C. The experimental groups were as follows: 1. Sham 1 (intraperitoneal [IP] injection of normal saline); 2. Sham 2 (intracerebroventricular [ICV] injection of artificial cerebrospinal fluid [ACSF]); 3. Experimental 1 (IP injection of ginseng extract); 4 and 5. Experimental groups 2 and 3 (IP injection of ginseng extract + bromocriptine 10 and 30 µg/rat by ICV injection); 6 and 7) experimental groups 4 and 5 (IP injection of ginseng extract + chlorpromazine 20 and 40 µg/rat by ICV injection). Ginseng extract 100 mg/kg/d was used for 7 days. Pain sensitivity test was done in all groups with the formalin test. Lateral ventricles of the rats were cannulated unilaterally by the stereotaxic procedure. Results: Our data showed that ginseng (100 mg/kg/d) significantly (P<0.05) decreased pain sensitivity compared to the sham 1 group. Bromocriptine in two doses significantly decreased pain sensitivity compared to the sham 2 group. Chlorpromazine in high doses significantly increased pain sensitivity compared to the sham 2 group. Conclusion: The present results indicate that ginseng can modulate the D2 receptor of the dopamine system in the control of pain sensitivity in the formalin test. Because bromocriptine and ginseng have similar effects, it seems that they had synergistic effects.
- 1 September 2020
- Published by Negah Scientific Publisher in Basic and Clinical Neuroscience Journal
- Vol. 11 (5) , 587-594
Open AccessEffects of Pretreatment With Ginseng Extract on Dopamine D2 Receptor Analgesi
Introduction: The ginseng extract is an herb that has been used for many purposes such as analgesic effect. Dopamine D2 receptors are involved in the regulation of pain in humans. Therefore, the present investigation aims to study how pretreatment with aqueous-alcoholic extract of ginseng can affect dopamine D2 receptors’ pain sensitivity. Methods: We used 45 adult male rats weighing 250±20 for this study. Animals were maintained in a standard condition at a temperature of 21°C-24°C. The experimental groups were as follows: 1. Sham 1 (intraperitoneal [IP] injection of normal saline); 2. Sham 2 (intracerebroventricular [ICV] injection of artificial cerebrospinal fluid [ACSF]); 3. Experimental 1 (IP injection of ginseng extract); 4 and 5. Experimental groups 2 and 3 (IP injection of ginseng extract + bromocriptine 10 and 30 µg/rat by ICV injection); 6 and 7) experimental groups 4 and 5 (IP injection of ginseng extract + chlorpromazine 20 and 40 µg/rat by ICV injection). Ginseng extract 100 mg/kg/d was used for 7 days. Pain sensitivity test was done in all groups with the formalin test. Lateral ventricles of the rats were cannulated unilaterally by the stereotaxic procedure. Results: Our data showed that ginseng (100 mg/kg/d) significantly (P<0.05) decreased pain sensitivity compared to the sham 1 group. Bromocriptine in two doses significantly decreased pain sensitivity compared to the sham 2 group. Chlorpromazine in high doses significantly increased pain sensitivity compared to the sham 2 group. Conclusion: The present results indicate that ginseng can modulate the D2 receptor of the dopamine system in the control of pain sensitivity in the formalin test. Because bromocriptine and ginseng have similar effects, it seems that they had synergistic effects.
- Open Access
- 1 January 2020
- Published by Wiley in BioMed Research International
- Vol. 2020 (1) , 2546365
The Cataleptic, Asymmetric, Analgesic, and Brain Biochemical Effects of Parkinson’s Disease Can Be Affected by Toxoplasma gondii Infection
Purpose. Parkinson’s disease (PD) is a neurodegenerative disorder with progressive motor defects. Therefore, the aim of the present investigation was to examine whether catalepsy, asymmetry, and nociceptive behaviors; the Nissl‐body and neuron distribution; brain‐derived neurotrophic factor (BDNF); malondialdehyde (MDA); total antioxidant capacity (TAC) levels; and the percentage of dopamine depletion of striatal neurons in the rat model of Parkinson’s disease (PD) can be affected by Toxoplasma gondii (TG) infection. Methods. Fifty rats were divided into five groups: control (intact rats), sham (rats which received an intrastriatal injection of artificial cerebrospinal fluid (ACSF)), PD control (induction of PD without TG infection), TG control (rats infected by TG without PD induction), and PD infected (third week after PD induction, infection by TG was done). PD was induced by the unilateral intrastriatal microinjection of 6‐hydroxydopamine (6‐OHDA) and ELISA quantified dopamine, BDNF, MDA, and TAC in the striatum tissue. Cataleptic, asymmetrical, nociceptive, and histological alterations were determined by bar test, elevated body swing test, formalin test, and Nissl‐body and neuron counting in the striatal neurons. Results. The results demonstrated that PD could significantly increase the number of biased swings, descent latency time, and nociceptive behavior and decrease the distribution of Nissl‐stained neurons compared to the control and sham groups. TG infection significantly improved biased swing, descent latency time, nociceptive behavior, and the Nissl‐body distribution in striatal neurons in comparison to the PD control group. The striatal level of BDNF in the PD‐infected and TG control groups significantly increased relative to the PD control group. The striatal MDA was significantly higher in the PD control than other groups, while striatal TAC was significantly lower in the PD control than other groups. Conclusions. The current study indicates that TG infection could improve the cataleptic, asymmetric, nociceptive and behaviors; the level of striatal dopamine release; BDNF levels; TAC; and MDA in PD rats.
- 1 January 2020
- Published by Wiley in BioMed Research International
- Vol. 2020 (1) , 2546365
Open AccessThe Cataleptic, Asymmetric, Analgesic, and Brain Biochemical Effects of Parkinson’s Disease Can Be Affected by Toxoplasma gondii Infection
Purpose. Parkinson’s disease (PD) is a neurodegenerative disorder with progressive motor defects. Therefore, the aim of the present investigation was to examine whether catalepsy, asymmetry, and nociceptive behaviors; the Nissl‐body and neuron distribution; brain‐derived neurotrophic factor (BDNF); malondialdehyde (MDA); total antioxidant capacity (TAC) levels; and the percentage of dopamine depletion of striatal neurons in the rat model of Parkinson’s disease (PD) can be affected by Toxoplasma gondii (TG) infection. Methods. Fifty rats were divided into five groups: control (intact rats), sham (rats which received an intrastriatal injection of artificial cerebrospinal fluid (ACSF)), PD control (induction of PD without TG infection), TG control (rats infected by TG without PD induction), and PD infected (third week after PD induction, infection by TG was done). PD was induced by the unilateral intrastriatal microinjection of 6‐hydroxydopamine (6‐OHDA) and ELISA quantified dopamine, BDNF, MDA, and TAC in the striatum tissue. Cataleptic, asymmetrical, nociceptive, and histological alterations were determined by bar test, elevated body swing test, formalin test, and Nissl‐body and neuron counting in the striatal neurons. Results. The results demonstrated that PD could significantly increase the number of biased swings, descent latency time, and nociceptive behavior and decrease the distribution of Nissl‐stained neurons compared to the control and sham groups. TG infection significantly improved biased swing, descent latency time, nociceptive behavior, and the Nissl‐body distribution in striatal neurons in comparison to the PD control group. The striatal level of BDNF in the PD‐infected and TG control groups significantly increased relative to the PD control group. The striatal MDA was significantly higher in the PD control than other groups, while striatal TAC was significantly lower in the PD control than other groups. Conclusions. The current study indicates that TG infection could improve the cataleptic, asymmetric, nociceptive and behaviors; the level of striatal dopamine release; BDNF levels; TAC; and MDA in PD rats.
- Open Access
- 1 September 2019
- Vol. 9 (5) , 465-473
Zataria multiflora could improve hippocampal tau protein and TNFα levels and cognitive behavior defects in a rat model of Alzheimer's disease
Objective: Zataria multiflora (ZM) is a plant with ethnopharmacological value which was recently tested to reduce symptoms of Alzheimer's disease (AD). The aim of the present study was to determine the effect of ZM essential oil on spatial cognitive and noncognitive behavior, as well as hippocampal tau protein and tumor necrosis factor alpha (TNF alpha) concentrations in rats with AD. Materials and Methods: Thirty-five adult male Sprague Dawley rats (300 +/- 30 g) were randomly divided into 5 groups: control (intact rats); sham (received intracerebroventricular (ICV) microinjection of normal saline); AD control (rats with AD that did not receive any treatment); vehicle control (rats with AD that orally received tween-80, 5% (ZM essential oil vehicle) for 20 days) and experimental (rats with AD that orally received ZM essential oil 100 mu l/kg/day for 20 days). AD was induced by bidirectional microinjection of beta amyloid 1-42 (10 mu g/2 mu l). Tau protein and TNF alpha concentrations were measured by ELISA methods. Spatial cognitive and noncognitive behavior were determined by Morris water maze (MWM) test. Results: ZM essential oil significantly improved latency time, time spent in the target quarter and cognitive behavior of rats with AD compared to control and sham groups (p<0.05). Hippocampal tau protein and TNF alpha concentrations were significantly higher in both AD control and vehicle groups compared to control and sham groups respectively (p<0.01 and p<0.001), administration of ZM essential oil reduced these parameters as compared to AD control and vehicle groups respectively (p<0.01 and p<0.001). Conclusion: ZM essential oil improves spatial learning and memory of rats with AD as assessed by MWM test. These effects are associated with decreased concentrations of hippocampal tau protein and TNF alpha.
- 1 September 2019
- Vol. 9 (5) , 465-473
Open AccessZataria multiflora could improve hippocampal tau protein and TNFα levels and cognitive behavior defects in a rat model of Alzheimer's disease
Objective: Zataria multiflora (ZM) is a plant with ethnopharmacological value which was recently tested to reduce symptoms of Alzheimer's disease (AD). The aim of the present study was to determine the effect of ZM essential oil on spatial cognitive and noncognitive behavior, as well as hippocampal tau protein and tumor necrosis factor alpha (TNF alpha) concentrations in rats with AD. Materials and Methods: Thirty-five adult male Sprague Dawley rats (300 +/- 30 g) were randomly divided into 5 groups: control (intact rats); sham (received intracerebroventricular (ICV) microinjection of normal saline); AD control (rats with AD that did not receive any treatment); vehicle control (rats with AD that orally received tween-80, 5% (ZM essential oil vehicle) for 20 days) and experimental (rats with AD that orally received ZM essential oil 100 mu l/kg/day for 20 days). AD was induced by bidirectional microinjection of beta amyloid 1-42 (10 mu g/2 mu l). Tau protein and TNF alpha concentrations were measured by ELISA methods. Spatial cognitive and noncognitive behavior were determined by Morris water maze (MWM) test. Results: ZM essential oil significantly improved latency time, time spent in the target quarter and cognitive behavior of rats with AD compared to control and sham groups (p<0.05). Hippocampal tau protein and TNF alpha concentrations were significantly higher in both AD control and vehicle groups compared to control and sham groups respectively (p<0.01 and p<0.001), administration of ZM essential oil reduced these parameters as compared to AD control and vehicle groups respectively (p<0.01 and p<0.001). Conclusion: ZM essential oil improves spatial learning and memory of rats with AD as assessed by MWM test. These effects are associated with decreased concentrations of hippocampal tau protein and TNF alpha.